Literature DB >> 22415640

Quantification of mass transfer during spheronisation.

Martin Koester1, Markus Thommes.   

Abstract

Spherical granules (pellets) are quite useful in many pharmaceutical applications. The extrusion spheronisation technique is well established as a method of producing pellets of a spherical shape and narrow size distribution. After the extrusion, the cylindrical extrudates are transformed to spherical pellets by spheronisation. The frequently used models consider deformation and breakage during this process. However, the adhesion of fine particles has been neglected as a mechanism in spheronisation for many years. This study quantifies the mass transfer between pellets during spheronisation. During the investigation, the pelletisation aids (microcrystalline cellulose and kappa-carrageenan), the drug (acetaminophen and ibuprofen) and water content were varied systematically. A novel parameter, namely, the "mass transfer fraction" (MTF), was defined to quantify the mass transfer between the pellets. All four investigated formulations had an MTF between 0.10 and 0.52 that implies that up to 50 % of the final pellet weight was involved in mass transfer. Both pelletisation aids showed similar MTF, independent of the drug used. Furthermore, an increase of the MTF, with respect to an increase of the water content, was found for microcrystalline cellulose formulations. In conclusion, the mass transfer between the pellets has to be considered as a mechanism for spheronisation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415640      PMCID: PMC3364402          DOI: 10.1208/s12249-012-9770-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation.

Authors:  C Lustig-Gustafsson; H Kaur Johal; F Podczeck; J M Newton
Journal:  Eur J Pharm Sci       Date:  1999-05       Impact factor: 4.384

2.  New insights into the pelletization mechanism by extrusion/spheronization.

Authors:  Martin Koester; Markus Thommes
Journal:  AAPS PharmSciTech       Date:  2010-11-02       Impact factor: 3.246

3.  Elucidation of spheroid formation with and without the extrusion step.

Authors:  Celine V Liew; Siang Meng Chua; Paul W S Heng
Journal:  AAPS PharmSciTech       Date:  2007-02-09       Impact factor: 3.246

Review 4.  Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.

Authors:  A Dukić-Ott; M Thommes; J P Remon; P Kleinebudde; C Vervaet
Journal:  Eur J Pharm Biopharm       Date:  2008-08-19       Impact factor: 5.571

5.  Comparison between a twin-screw extruder and a rotary ring die press. Part II: influence of process variables.

Authors:  C Schmidt; P Kleinebudde
Journal:  Eur J Pharm Biopharm       Date:  1998-03       Impact factor: 5.571

6.  Use of powdered cellulose for the production of pellets by extrusion/spheronization.

Authors:  H Lindner; P Kleinebudde
Journal:  J Pharm Pharmacol       Date:  1994-01       Impact factor: 3.765

7.  Preliminary assessment of carrageenan as excipient for extrusion/spheronisation.

Authors:  Martin Bornhöft; Markus Thommes; Peter Kleinebudde
Journal:  Eur J Pharm Biopharm       Date:  2005-01       Impact factor: 5.571

8.  Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables.

Authors:  Anjali M Agrawal; Matthew A Howard; Steven H Neau
Journal:  Pharm Dev Technol       Date:  2004       Impact factor: 3.133

9.  The behavior of different carrageenans in pelletization by extrusion/spheronization.

Authors:  Markus Thommes; Peter Kleinebudde
Journal:  Pharm Dev Technol       Date:  2008       Impact factor: 3.133

10.  Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.

Authors:  Markus Thommes; Peter Kleinebudde
Journal:  AAPS PharmSciTech       Date:  2007-11-09       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.